Nicholas Piramal Considers Taking Partner In R&D Spinoff (India)
This article was originally published in PharmAsia News
Executive Summary
India's Nicholas Piramal is considering a partner when it spins off its research and development arm into a new company later this year. Chairman Ajay Piramal said many investors are interested in being that partner, but the firm has not decided whether to go in that direction. Piramal said the split remains on track and could be completed by May or June if the move gets regulatory approval, as expected, before February. The company currently is developing 13 new chemical entities, including eight now in clinical trials. (Click here for more